Home

Andrew I McDonald

CIK 1734292 · Chief Executive Officer · last filed 2022-05-31

Andrew I McDonald is a Chief Executive Officer who has filed 8 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for VINC, was dated May 31, 2022. Across all open-market trades the lifetime net is +$247.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $10.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.5K

Companies

4

Total Filings

8

Lifetime Open-Market Net

$247.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VINC Director 828,471 $0.01 $10.5K $247.6K 3 2022-05-31
Science 37 Holdings, Inc. (LSAQ) Delisted Chief Executive Officer 1,772,034 $9.01 $15.97M $0 2 2021-08-26
Vincerx Pharma, Inc. (VINCW) Delisted Director 808,471 $1.61 $1.30M $0 2 2021-02-02
Vincerx Pharma, Inc. (LSACU) Delisted Chief Executive Officer — — — $0 1 2020-03-12

Recent Filings

8 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-05-31 VINC Grant (A) — $0 EDGAR
2021-08-26 Science 37 Holdings, Inc. (LSAQ) Delisted Other (J) −138,591 $0 EDGAR
2021-07-01 VINC Buy (P) +20,000 $247.6K EDGAR
2021-05-14 VINC Grant (A) — $0 EDGAR
2021-02-02 Vincerx Pharma, Inc. (VINCW) Delisted Other (J) −808,471 $0 EDGAR
2020-12-28 Vincerx Pharma, Inc. (VINCW) Delisted Grant (A) — $0 EDGAR
2020-11-25 Science 37 Holdings, Inc. (LSAQ) Delisted Grant (A) — $0 EDGAR
2020-03-12 Vincerx Pharma, Inc. (LSACU) Delisted Grant (A) — $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.